•Based on the "gut microbiota-barrier-immunity" axis to explore the mechanism of action of traditional Chinese medicine polysaccharides in the treatment of inflammatory bowel disease and structure-activity relationship: A review
•Risk of serious infection, myocardial infarction, stroke, and thromboembolic events in patients in the United States with ulcerative colitis treated with tofacitinib compared with biologic treatments
•The ImproveCareNow Registry: Prediction of remission rates in paediatric Crohn's disease
•Cell cycle dysregulation: a central hub in colitis-associated colorectal carcinogenesis
•Remote monitoring to improve engagement for patients with inflammatory bowel disease: a randomized clinical trial
